Intracameral cefuroxime and the incidence of post-cataract endophthalmitis: an Israeli experience.

Purpose: The European Society of Cataract & Refractive Surgeons (ESCRS) study reported a decrease in endophthalmitis rates from 0.34 % to 0.08 % with the use of intracameral cefuroxime.